Peter Vuylsteke
Impact in
- Oncology top 2%
- PARP inhibition in cancer therapy
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 44
- HER2/EGFR in Cancer Research 11
- Cancer Immunotherapy and Biomarkers 8
- PARP inhibition in cancer therapy 8
- Cancer Treatment and Pharmacology 7
-
- Advanced Breast Cancer Therapies 12
- Co-authors
- Gabe S. Sonke (6 shared papers)Marie Plante (3 shared papers)Amit M. Oza (3 shared papers)Jiří Špaček (3 shared papers)Sven Mahner (2 shared papers)Ron H.J. Mathijssen (3 shared papers)Jacqui Rowbottom (2 shared papers)David Cibula (3 shared papers)
- Journals
- Journal of Clinical Oncology (18 papers)Annals of Oncology (12 papers)Cancer Research (7 papers)JCO Global Oncology (6 papers)Breast Cancer Research and Treatment (4 papers)
- Partner nations
- BelgiumUnited StatesGermany
In The Last Decade
Peter Vuylsteke
95 papers receiving 1.8k citations
Peter Vuylsteke's Hit Papers
Peers
Comparison fields: 5 of 86
- Oncology 981
- Reproductive Medicine 280
- Cancer Research 346
- Pulmonary and Respiratory Medicine 339
- Geriatrics and Gerontology 32
Countries citing papers authored by Peter Vuylsteke
This map shows the geographic impact of Peter Vuylsteke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Vuylsteke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Vuylsteke more than expected).
Fields of papers citing papers by Peter Vuylsteke
This network shows the impact of papers produced by Peter Vuylsteke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Vuylsteke. The network helps show where Peter Vuylsteke may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Vuylsteke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 106 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial Hit paper breakdown → | 2014 | 452 |
| 2 | 2013 | 107 | |
| 3 | 2016 | 95 | |
| 4 | 2018 | 84 | |
| 5 | 2015 | 71 | |
| 6 | 2014 | 60 | |
| 7 | 2023 | 60 | |
| 8 | 2018 | 56 | |
| 9 | 2012 | 51 | |
| 10 | 2019 | 50 | |
| 11 | 2013 | 47 | |
| 12 | 2016 | 43 | |
| 13 | 2020 | 41 | |
| 14 | 2010 | 41 | |
| 15 | 2013 | 34 | |
| 16 | 2004 | 31 | |
| 17 | 2019 | 27 | |
| 18 | 2016 | 21 | |
| 19 | 2015 | 18 | |
| 20 | Treatment algorithm in patients with ovarian cancer. | 2020 | 18 |
About Peter Vuylsteke
Peter Vuylsteke is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Reproductive Medicine, Cancer Research and Surgery, having authored 106 papers that have together received 1.8k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (13 papers), Advanced Breast Cancer Therapies (12 papers), HER2/EGFR in Cancer Research (11 papers), Breast Cancer Treatment Studies (9 papers), Cervical Cancer and HPV Research (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), PARP inhibition in cancer therapy (8 papers) and Cancer Treatment and Pharmacology (7 papers). The work is most often cited by research in Oncology (981 citations), Reproductive Medicine (280 citations), Cancer Research (346 citations), Pulmonary and Respiratory Medicine (339 citations) and Geriatrics and Gerontology (32 citations). Peter Vuylsteke has collaborated with scholars based in Belgium, United States and Germany. Frequent co-authors include Gabe S. Sonke, Marie Plante, Amit M. Oza, Jiří Špaček, Sven Mahner, Ron H.J. Mathijssen, Jacqui Rowbottom, David Cibula, Helen Mackay and Michael Friedländer. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, JCO Global Oncology and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.